Organigram Holdings Inc. (OGI:NSD) is seeing a rise in interest from analysts and investors alike. Investment analysts at Alliance Global Partners recently issued their FY2025 earnings predictions for the Organigram stock, with a forecast of ($0.04) per share for the year. This estimate is slightly above the consensus prediction for the current full-year earnings, which is ($0.06) per share.
This positive outlook for the company’s earnings has led to a rise in the Organigram stock value. On Monday, OGI stock opened at $0.99, up 10% from the previous day’s closing.
The company has a market cap of $310.69 million, a PE ratio of -33.00, and a beta of 0.82. The company’s 50-day moving average is $0.92 and its two-hundred-day moving average is $0.98.
Organigram Stock-Analyst Ratings:
Other analysts have also recently weighed in on the Organigram stock. Raymond James lowered their price target on shares of Organigram from C$3.00 to C$2.00 in a research report on Wednesday, January 11th.
However, Stifel Nicolaus raised Organigram’s rating from “hold” to “buy” in a research note on Friday.
Hedge Funds & Institutional Holdings:
In addition to analysts, several hedge funds and institutional investors have recently made changes to their positions in the company.
Renaissance Technologies LLC increased their holdings in Organigram by 362.5% in the second quarter.
Goldman Sachs Group Inc. also grew its position in the company by 137.8% in the first quarter.
Other institutions such as AdvisorShares Investments LLC, Millennium Management LLC, and Merlin Capital LLC also made significant investments in the company. Overall, institutional investors own 10.98% of the Organigram stock.
All of this positive outlook for Organigram Holdings Inc. may be an indication of a promising future for the company. With analysts forecasting strong earnings and institutions investing heavily in the company, it’s worth keeping an eye on Organigram’s progress in the coming years.
Company Profile:
Organigram Holdings Inc., through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada.
It offers medical cannabis products, including cannabis flowers, gummies, cannabis oils, and vaporizers for civilian patients and veterans; adult use recreational cannabis under the SHRED, Big Bag O’ Buds, Monjour, SHRED’ems, Edison Cannabis Co., Edison JOLTS, Tremblant, and Laurentian brands; and cannabis edibles products and concentrates.
The company also engages in the wholesale shipping of cannabis plant cuttings, dried flowers, blends, pre-rolls, and cannabis derivative-based products to retailers and wholesalers for adult-use recreational cannabis.
It sells its products online, as well as telephone channels. Organigram Holdings Inc. was incorporated in 2010 and is headquartered in Toronto, Canada.
